FE Exclusive | We are planning to expand our therapeutic footprint in complex molecules & high-demand disease areas: Dr. Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions
- Posted on November 12, 2024
- By Financial Express
- 1 Views
FE Exclusive | We are planning to expand our therapeutic footprint in complex molecules & high-demand disease areas: Dr. Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions
Lupin entered into the CDMO business last year in June with the launch of its new subsidiary Lupin Manufacturing Solutions with an intent to build out its contract development and manufacturing operations business in India.
